Clinical Trial Update: A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II study of WJ22096 Tablets in patients with advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• WJ22096 Tablets

Snippet

Sponsor: Nanjing Jingao biomidical technology Co. Ltd. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING